PubMed中文版

检索结果 38528
原始关键字 阿尔茨海默病 治疗 
转化关键字 ((TITLE_ABS:("Alzheimer's disease" treatment)) OR (KW:("Alzheimer's disease" treatment))) AND SRC:MED 


影响因子

出版日期
文献类型
物种
PubMed ID 40266549
发表日期 2025-04-23
作者 Kakeda S, Miki Y, Kudo K, Mori H, Tokumaru AM, Abe O, Aoki S, Working Group for Brain MRI Guidelines for Anti-Aβ Antibody Treatment from The Japan Radiological Society, The Japanese Society for Neuroradiology, and The Japanese Society for Magnetic Resonance in Medicine.
文献标题 Practical brain MRI guidelines for anti-Aβ antibody treatment in early symptomatic Alzheimer's disease.
原始出处 Jpn J Radiol
影响因子 2.1   期刊引文指标 0.61

PubMed ID 40189473
发表日期 2025-04-05
作者 Chen C, Katayama S, Lee JH, Lee JY, Nakagawa M, Torii K, Ogawa T, Dash A, Irizarry M, Dhadda S, Kanekiyo M, Hersch S, Iwatsubo T.
文献标题 Clarity AD: Asian regional analysis of a phase III trial of lecanemab in early Alzheimer's disease.
原始出处 J Prev Alzheimers Dis
影响因子 6.4   期刊引文指标 1.41

PubMed ID 40245176
发表日期 2025-04-01
作者 Liu Z, Zhang J, Jiang F, Liu C, Shao Y, Le W.
文献标题 Biological Effects of Dietary Restriction on Alzheimer's Disease: Experimental and Clinical Investigations.
原始出处 CNS Neurosci Ther
影响因子 5.5   期刊引文指标 1.3

PubMed ID 40291121
发表日期 2025-04-24
作者 Perneczky R, Froelich L.
文献标题 Clinically meaningful benefit and real-world evidence in Alzheimer's disease research and care.
原始出处 Alzheimers Dement (N Y)
影响因子 4.8   期刊引文指标 1.28

PubMed ID 40112319
发表日期 2025-03-20
作者 Fuseya K, Mimura Y, Nakajima S, Mimura M, Kasanuki K, Noda Y.
文献标题 A systematic review and meta-analysis on the characteristics of transcranial magnetic stimulation treatment protocols for patients with Alzheimer's disease.
原始出处 J Alzheimers Dis
影响因子 4   期刊引文指标 0.85

PubMed ID 40034522
发表日期 2025-01-31
作者 Chaudhuri I, Das S.
文献标题 Heterogeneous treatment effects of BCG vaccine on Alzheimer's disease risk.
原始出处 J Alzheimers Dis Rep
影响因子 3.2   期刊引文指标 0.57

PubMed ID 39868614
发表日期 2025-01-27
作者 Liu KY, Senn S, Howard R.
文献标题 Avoiding causal fraud in the evaluation of clinical benefits of treatments for Alzheimer's disease.
原始出处 Alzheimers Dement
影响因子 14   期刊引文指标 3.74

PubMed ID 39665306
发表日期 2025-01-01
作者 Zhang N, Nao J, Dong X.
文献标题 Efficacy and Safety of Natural Apigenin Treatment for Alzheimer's Disease: Focus on In vivo Research Advancements.
原始出处 Curr Neuropharmacol
影响因子 5.3   期刊引文指标 0.82

PubMed ID 39740290
发表日期 2024-12-30
作者 Yang Y, Drake SA, Wang J, Shen GC, Miao H, Morgan RO, Du XL, Lairson DR.
文献标题 Comparing total medical costs of surgical treatment versus nonoperative care for femoral neck fractures among Alzheimer's disease patients: A retrospective cohort study.
原始出处 Geriatr Nurs
影响因子 2.525   期刊引文指标 0.79

PubMed ID 39651698
发表日期 2024-12-09
作者 Cai J, Liu Y, Fan H.
文献标题 Review on pathogenesis and treatment of Alzheimer's disease.
原始出处 Dev Dyn
影响因子 2.5   期刊引文指标 0.87

PubMed ID 39623797
发表日期 2024-12-02
作者 Ding Q, Zhao Y, Xi E, Liu K, Gao N, Zhu G.
文献标题 Constructing a Metal-Organic Frameworks-Based Long-Acting Sequential Release System for the Treatment of Alzheimer's Disease.
原始出处 Adv Healthc Mater
影响因子 10   期刊引文指标 1.3

PubMed ID 39637477
发表日期 2024-11-26
作者 Abeysinghe S, Tao Y, Kyei-Baffour P, Adrion E.
文献标题 'Small benefits and a certain risk': Media representations of novel treatments for Alzheimer's disease.
原始出处 Soc Sci Med
影响因子 5.4   期刊引文指标 1.6

PubMed ID 39648108
发表日期 2024-11-19
作者 Aga VM.
文献标题 Brexpiprazole for the Treatment of Agitation in Alzheimer's Disease Dementia: Clinical Uncertainties and the Path Forward.
原始出处 Am J Geriatr Psychiatry
影响因子 7.996   期刊引文指标 1.48

PubMed ID 39638097
发表日期 2024-12-03
作者 Arroyo-Pacheco N, Sarmiento-Blanco S, Vergara-Cadavid G, Castro-Leones M, Contreras-Puentes N.
文献标题 Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis.
原始出处 Ageing Res Rev
影响因子 13.1   期刊引文指标 1.53

PubMed ID 39534972
发表日期 2024-11-13
作者 Behl S, Slomkowski M, Chen D, Chang D, Hefting N, Lee D, Shah A, Estilo A, Kalu U, Hobart M.
文献标题 Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial.
原始出处 J Alzheimers Dis
影响因子 4   期刊引文指标 0.85

PubMed ID 39460576
发表日期 2024-10-26
作者 Deng T, Yu W, Lü Y.
文献标题 Different physical exercise in the treatment of Alzheimer's disease.
原始出处 Psychogeriatrics
影响因子 2.295   期刊引文指标 0.46

PubMed ID 39280110
发表日期 2024-08-27
作者 Sabu A, Huang YC, Sharmila R, Sun CY, Shen MY, Chiu HC.
文献标题 Magnetic stirring with iron oxide nanospinners accretes neurotoxic Aβ42 oligomers into phagocytic clearable plaques for Alzheimer's disease treatment.
原始出处 Mater Today Bio
影响因子 8.2   期刊引文指标 1.34

PubMed ID 39101248
发表日期 2024-08-05
作者 Song Q, Li J, Li T, Li HW.
文献标题 Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood-Brain Barrier Crossing Ability.
原始出处 Adv Sci (Weinh)
影响因子 15.1   期刊引文指标 2.1

PubMed ID 38757165
发表日期 2024-05-15
作者 Singh D, Kurmi BD, Singh A.
文献标题 Graphene Oxide, a Prominent Nanocarrier to Reduce the Toxicity of Alzheimer's Proteins: A Revolution in Treatment.
原始出处 Recent Pat Nanotechnol
影响因子 2.321   期刊引文指标 0.2

PubMed ID 38577023
发表日期 2024-03-16
作者 Wu X, Xia P, Yang L, Lu C, Lu Z.
文献标题 The roles of long non-coding RNAs in Alzheimer's disease diagnosis, treatment, and their involvement in Alzheimer's disease immune responses.
原始出处 Noncoding RNA Res
影响因子 5   期刊引文指标 0.69